Investors should consider Zeta Global (ZETA) as an undervalued AI-powered advertising play, currently growing at 35% with a proprietary data advantage that makes it a cheaper alternative to The Trade Desk (TTD). Hims & Hers Health (HIMS) offers a high-conviction opportunity to capitalize on the GLP-1 weight loss trend and international expansion, trading at an irrational discount despite pristine fundamentals. Meta Platforms (META) remains the most attractive "Magnificent 7" stock, with potential to double in price as it monetizes WhatsApp and transitions users toward high-margin subscription models. For fintech exposure, SoFi Technologies (SOFI) is a preferred value pick over Nubank (NU), as its diversification into fee-based services like brokerage and IPOs is currently overshadowed by temporary interest rate fears. Finally, Real Brokerage (REAX) is a high-risk, high-reward small-cap play growing at 50% annually; investors should consider a small position following its recent price drop to benefit from its AI-driven disruption of traditional real estate.

Zeta Global (ZETA)

• Zeta is described as a "next-gen" advertising business that utilizes an AI-powered graph to target consumers.
• Proprietary Advantage: The company owns a mapping of approximately 300 million people in the US (and potentially up to a billion globally), allowing them to follow users through the web more effectively than competitors.
• Growth Metrics: The company is growing at roughly 35% for the next 12 months and is currently profitable.
• Valuation: The analyst uses a custom EV/GP/RG (Enterprise Value / Gross Profit / Revenue Growth) metric, placing Zeta at 0.16, which he considers cheap compared to competitors like The Trade Desk (TTD).

Takeaways

• Bullish Sentiment: Viewed as a superior alternative to traditional ad-tech firms due to its proprietary data "phone book."
• Actionable Insight: Investors looking for exposure to AI in advertising might find Zeta a more "undervalued" play than larger, more famous peers.

Hims & Hers Health (HIMS)

• The stock has experienced high volatility, dropping significantly (approx. 20% since early June) despite what the analyst calls "pristine" fundamentals.
• GLP-1 Catalyst: HIMS has a partnership to sell Eli Lilly products and is becoming a major purveyor of GLP-1 (weight loss) medications.
• Acquisition Growth: The recent acquisition of Eucalyptus (an Australian telehealth company) is expected to add $450 million in Annual Recurring Revenue (ARR), which the analyst claims is not yet fully baked into market guidance.
• Market Mispricing: The analyst argues the stock is being treated as a "punching bag" for the healthcare sector and is trading at an irrational discount (0.1 on his valuation scale).

Takeaways

• Bullish Sentiment: The analyst believes the market is "broken" regarding HIMS, ignoring massive revenue catalysts from GLP-1s and international expansion.
• Risk Factor: Extreme volatility; the stock often trades in correlation with "risk-off" assets like Bitcoin rather than on its own financial merits.

Meta Platforms (META)

• Meta is identified as the cheapest of the "Magnificent 7" stocks with a valuation of 0.37 on the analyst's scale.
• AI & Monetization: While the market is wary of Meta's heavy AI spending, the analyst argues this compute power will lead to "one-to-one marketing" and highly addictive ad products.
• Product Success: The Meta Ray-Ban glasses are cited as a "worldwide hit," and the analyst believes WhatsApp remains heavily under-monetized.
• Subscription Playbook: Prediction that Meta will follow the "YouTube Premium" model, making Instagram/WhatsApp "unbearable" with ads to force users into $9.99/month subscriptions.

Takeaways

• Bullish Sentiment: Considered a "pristine asset" that is unjustly discounted compared to Nvidia or other tech giants.
• Actionable Insight: The analyst sees a potential "double" in stock price if it returns to a valuation in line with its peers (0.6 scale).

SoFi Technologies (SOFI)

• The stock has been "halved" (down ~43% in six months) primarily due to fears that interest rates will remain high.
• Business Shift: The analyst argues the market incorrectly views SoFi as just a "student loan company," ignoring its growth in fee-based businesses (ETFs, brokerage, IPO launches like SpaceX).
• Comparison to Nubank (NU): The analyst currently prefers SoFi over Nubank because SoFi is cheaper and lacks the specific regulatory risks currently facing fintechs in Brazil.

Takeaways

• Bullish Sentiment: Viewed as a victim of "rate fears" that ignore the company's diversification into non-lending revenue.
• Actionable Insight: For investors choosing between American and Latin American fintech, the analyst suggests SoFi offers better value at current depressed prices.

Real Brokerage (REAX)

• A small-cap "under the radar" real estate brokerage app that has grown at 50% for the past five years.
• Recent Dump: The stock fell 25% recently following the announcement of its acquisition of RE/MAX.
• The Strategy: Real Brokerage plans to move RE/MAX’s massive agent count onto its high-efficiency, AI-driven backend app to realize major cost synergies.
• Valuation: Described as "nonsensical" at 0.03 on the analyst's metric, with a Rule of 40 score of 54.

Takeaways

• Bullish Sentiment: High conviction in the technology's ability to disrupt traditional brokerage models.
• Risk Factor: Extremely high volatility and low trading volume. The analyst recommends this only as a "small position" that investors should "forget about" to avoid stress.

Investment Themes & Sector Insights

• EV/GP/RG Metric: The analyst prefers using Gross Profit over Earnings because modern tech companies reinvest heavily in marketing and R&D, which he views as assets rather than losses.
• "Cheap Growth": The overarching theme is finding hyper-growth companies (30%+ growth) that are currently "dumped" by the market due to macro fears (interest rates) rather than fundamental business failure.
• Market Correlation: A warning that "risk-on" stocks currently move in lockstep; when Bitcoin or the general market drops, these stocks are often sold off indiscriminately regardless of their individual performance.